128 related articles for article (PubMed ID: 17443897)
1. [Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
Peng F; Fang SH; Zheng XL; Zhang WP; Lu YB; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):123-8. PubMed ID: 17443897
[TBL] [Abstract][Full Text] [Related]
2. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells.
Ishinaga H; Takeuchi K; Kishioka C; Suzuki S; Basbaum C; Majima Y
Pharmacology; 2005 Feb; 73(2):89-96. PubMed ID: 15475658
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
[TBL] [Abstract][Full Text] [Related]
6. [Study on the effect of cysteinyl leukotriene antagonist, pranlukast hydrate, on adhesive interaction between eosinophils and pulmonary endothelial cells].
Nogimura M; Nagata M; Sutani A; Saito K; Sakamoto Y
Nihon Kokyuki Gakkai Zasshi; 2002 Dec; 40(12):919-24. PubMed ID: 12692940
[TBL] [Abstract][Full Text] [Related]
7. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
8. [Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons].
Hu X; Ge QF; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):117-22. PubMed ID: 17443896
[TBL] [Abstract][Full Text] [Related]
9. [Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells].
Cai BL; Wang XX; Yu SY; Huang XQ; Zhang XY; Fang SH; Lu YB; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):139-44. PubMed ID: 21488208
[TBL] [Abstract][Full Text] [Related]
10. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
12. CysLT1 receptor antagonists pranlukast and zafirlukast inhibit LRRC8-mediated volume regulated anion channels independently of the receptor.
Figueroa EE; Kramer M; Strange K; Denton JS
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C857-C866. PubMed ID: 31390227
[TBL] [Abstract][Full Text] [Related]
13. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of cysteinyl leukotriene receptors on human platelets.
Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion.
Profita M; Sala A; Bonanno A; Siena L; Ferraro M; Di Giorgi R; Montalbano AM; Albano GD; Gagliardo R; Gjomarkaj M
J Pharmacol Exp Ther; 2008 Jun; 325(3):1024-30. PubMed ID: 18305014
[TBL] [Abstract][Full Text] [Related]
16. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC; Khawaja AM; Rogers DF
Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of cysteinyl leukotriene receptor 1 is involved in oxygen-glucose deprivation-induced damage to endothelial cells.
Fang SH; Lin KN; Huang XQ; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2012 Dec; 33(12):1511-7. PubMed ID: 23085741
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
